Enterolactis Plus

Lactobacillus casei DG · SOFAR S.p.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Enterolactis Plus, covering 2016-02-02 to 2016-02-02. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Lactobacillus Casei DG (Enterolactis Plus®) in Patient With Irritable Bowel Syndrome: a Pilot Study [NA]

See pricing